Second, while our data underscore the pivotal role of TIM-3 expression on DCs in orchestrating robust anti-tumor immunity, the precise molecular mechanisms underlying OVV-NbTIM3-mediated DCs activation require further mechanistic dissection in future investigations. Here, HAVCR2 is linked to neoplasm.